Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruhiko Fukuda

Showing results (11-20 of 222) with videos related to

Pageof 23
Sort By:
Annals of Surgical Oncology|March 8, 2012
The role of adjuvant chemotherapy for localized squamous cell esophageal cancer: current Japanese standard and the unending role of the drawing boardYuko Kitagawa, Nobutoshi Ando, Kenichi Nakamura, et al.
Japanese Journal of Clinical Oncology|April 5, 2002
The Influence of handling censored data on estimating progression-free survival in cancer clinical trials (JCOG9913-A)Miyuki Niimi, Seiichiro Yamamoto, Haruhiko Fukuda, et al.
Japanese Journal of Clinical Oncology|July 31, 2012
Evaluation of three definitions of progression-free survival in preoperative cancer therapy (JCOG0801-A)Kenichi Nakamura, Taro Shibata, Atsuo Takashima, et al.
Japanese Journal of Clinical Oncology|July 23, 2019
Study risk assessment of Japan Clinical Oncology Group (JCOG) clinical trials using the European Organisation for Research and Treatment of Cancer (EORTC) study risk calculatorKenichi Miyamoto, Kenichi Nakamura, Junki Mizusawa, et al.
Japanese Journal of Clinical Oncology|January 22, 2009
Preoperative and postoperative chemotherapy with ifosfamide and adriamycin for adult high-grade soft-tissue sarcomas in the extremities: Japan Clinical Oncology Group Study JCOG0304Kazuhiro Tanaka, Hiroshi Kawamoto, Isamu Saito, et al.
Japanese Journal of Clinical Oncology|March 17, 2004
Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206Takashi Onda, Toshiharu Kamura, Naoki Ishizuka, et al.
Gastroenterology|October 14, 2022
Final Analysis of Diagnostic Endoscopic Resection Followed by Selective Chemoradiotherapy for Stage I Esophageal Cancer: JCOG0508Keiji Nihei, Keiko Minashi, Tomonori Yano, et al.
Japanese Journal of Clinical Oncology|October 1, 2019
Geriatric Research Policy: Japan Clinical Oncology Group (JCOG) policyTomonori Mizutani, Kenichi Nakamura, Haruhiko Fukuda, et al.
Annals of Surgical Oncology|March 19, 2013
Which is the optimal response criteria for evaluating preoperative treatment in esophageal cancer: RECIST or histology?Yukinori Kurokawa, Taro Shibata, Nobutoshi Ando, et al.
World Journal of Surgical Oncology|April 20, 2016
Prospective evaluation of Ki-67 system in histological grading of soft tissue sarcomas in the Japan Clinical Oncology Group Study JCOG0304Kazuhiro Tanaka, Tadashi Hasegawa, Takayuki Nojima, et al.
Pageof 23

Showing results (11-20 of 222) with videos related to

Sort By:
Pageof 23
Annals of Surgical Oncology|March 8, 2012
The role of adjuvant chemotherapy for localized squamous cell esophageal cancer: current Japanese standard and the unending role of the drawing boardYuko Kitagawa, Nobutoshi Ando, Kenichi Nakamura, et al.
Japanese Journal of Clinical Oncology|April 5, 2002
The Influence of handling censored data on estimating progression-free survival in cancer clinical trials (JCOG9913-A)Miyuki Niimi, Seiichiro Yamamoto, Haruhiko Fukuda, et al.
Japanese Journal of Clinical Oncology|July 31, 2012
Evaluation of three definitions of progression-free survival in preoperative cancer therapy (JCOG0801-A)Kenichi Nakamura, Taro Shibata, Atsuo Takashima, et al.
Japanese Journal of Clinical Oncology|July 23, 2019
Study risk assessment of Japan Clinical Oncology Group (JCOG) clinical trials using the European Organisation for Research and Treatment of Cancer (EORTC) study risk calculatorKenichi Miyamoto, Kenichi Nakamura, Junki Mizusawa, et al.
Japanese Journal of Clinical Oncology|January 22, 2009
Preoperative and postoperative chemotherapy with ifosfamide and adriamycin for adult high-grade soft-tissue sarcomas in the extremities: Japan Clinical Oncology Group Study JCOG0304Kazuhiro Tanaka, Hiroshi Kawamoto, Isamu Saito, et al.
Japanese Journal of Clinical Oncology|March 17, 2004
Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206Takashi Onda, Toshiharu Kamura, Naoki Ishizuka, et al.
Gastroenterology|October 14, 2022
Final Analysis of Diagnostic Endoscopic Resection Followed by Selective Chemoradiotherapy for Stage I Esophageal Cancer: JCOG0508Keiji Nihei, Keiko Minashi, Tomonori Yano, et al.
Japanese Journal of Clinical Oncology|October 1, 2019
Geriatric Research Policy: Japan Clinical Oncology Group (JCOG) policyTomonori Mizutani, Kenichi Nakamura, Haruhiko Fukuda, et al.
Annals of Surgical Oncology|March 19, 2013
Which is the optimal response criteria for evaluating preoperative treatment in esophageal cancer: RECIST or histology?Yukinori Kurokawa, Taro Shibata, Nobutoshi Ando, et al.
World Journal of Surgical Oncology|April 20, 2016
Prospective evaluation of Ki-67 system in histological grading of soft tissue sarcomas in the Japan Clinical Oncology Group Study JCOG0304Kazuhiro Tanaka, Tadashi Hasegawa, Takayuki Nojima, et al.
Pageof 23